Trimetazidine – Cardiology MCQ
Trimetazidine is an antianginal agent which acts by inhibition of:
A. Beta oxidation of fatty acids
B. Anaerobic metabolism of glucose
C. Calcium channels
D. Beta adrenergic receptors
Please check the YouTube video above for discussion
Related Posts
-
Pickering syndrome – Cardiology MCQ
No Comments | Aug 7, 2020
-
HCM exercise BP – Cardiology MCQ
No Comments | Apr 21, 2018
-
Contrast induced renal injury – Cardiology MCQ
No Comments | Nov 1, 2016
-
RSOV with low shunt – Cardiology MCQ
No Comments | Jul 27, 2014
About The Author
Johnson Francis
Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal